check_circleStudy Completed
CE in MRI: Liver
Bayer Identifier:
13358
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
EU CT Number:
Not Available
Primovist: DDI with OATP-Inhibitor
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
18 YearsTrial summary
Enrollment Goal
12Trial Dates
May 2009 - July 2009Phase
Phase 1Could I Receive a placebo
N/AProducts
Eovist/Primovist (Gadoxetate disodium, BAY86-4873)Accepts Healthy Volunteer
N/AWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Bayer Schering Pharma AG | Berlin, 13353, Germany |
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A